The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes

Nephron

Volumn 92, Issue 1, 2002, Pages 72-76

  De Cosmo, Salvatore ^a   Tassi, V ^a   Thomas, S ^e   Piras, G P ^b   Trevisan, R ^c   Cavallo Perin, P ^d   Bacci, S ^a   Zucaro, L ^a   Cisternino, C ^a   Trischitta, V ^a,f   Viberti, G C ^e  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b BROTZU HOSPITAL   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Institute of Internal Medicine   (Italy)

^e GUY S HOSPITAL   (United Kingdom)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Diabetic nephropathy; Gene polymorphism; Proteinuria; Serum creatinine

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DECORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; EUROPE; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY;

ADULT; ALLELES; CELLS, CULTURED; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROTEINURIA; PROTEOGLYCANS; SKIN;

EID: 18544388557     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064470     Document Type: Article

References (29)

1. Promoters of progression of diabetic nephropathy: The relative roles of blood glucose and blood pressure control
2. Pathophysiology of progressive nephropathies
3. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus
4. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: Observational follow-up study
5. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: Findings from the EUCLID randomised controlled trial. EURODIAB controlled trial of Lisinopril in IDDM
6. Contribution of genetic polymorphism of the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes
7. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria
8. Glomerular structure and function in diabetic nephropathy: Early to advanced stages
9. Expression of transforming growth factor is elevated in human and experimental diabetic nephropathy
10. Negative regulation of transforming growth factor by the proteoglycan decorin
11. Transforming growth factor in diabetic nephropathy
12. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia
13. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
14. What is the role of decorin in diabetic kidney disease?
15. Length polymorphism within a complex dinucleotide repeat in the human decorin (DCN) gene
16. Prediction of creatinine clearance from serum creatinine
17. How accurate is derived creatinine clearance (CrCl) as a measure of progression of diabetic kidney disease (DKD)?
18. Statistical methods for assessing agreement between two methods of clinical measurement
19. Molecular cloning
20. ACE, PAI-1, Decorin and Werner Helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes
21. Genetic factors in the development and progression of renal disease in type 1 diabetic patients
22. Metabolic control and progression of diabetic nephropathy
23. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients
24. Genetics of diabetic nephropathy: Evidence for major and minor gene effect
25. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies Gruppo Italiano Studio Epidemiologia in Nefrologia (GISEN)
26. Progression of diabetic nephropathy in normotensive type 1 diabetic patients
27. Long-term renoprotective effect of Lisinopril in patients with diabetic nephropathy
28. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix
29. Contribution of angiotensin I converting enzyme I/D polymorphism to the development and progression of nephropathy in type 1 diabetes